Tuesday 5 October 2010

Think tank: targeted medicines, drug delivery mechanisms, and virtual monitoring tools

Technological advancements and new business models incorporating more than one of the various industry sectors: the trend towards convergence does not spare the healthcare industry.  A clear separation between medical devices, healthcare technologies and life sciences is increasingly difficult. Yet the convergence of all areas opens the door to a new era, enabling personalisation, targeted medicines, new drug delivery mechanisms, and virtual patient monitoring tools, while allowing a preventative approach to healthcare at the same time.

In order to learn how to tackle some of these challenging issues regarding the future of Healthcare, Frost & Sullivan is hosting its’ first interactive Think Tank ‘Converging towards Integrated Healthcare’ on Wednesday, 10th November 2010, in London.
The one-day interactive workshop is designed for senior decision makers in the healthcare industry and will focus on the commercial implications and opportunities offered by global social, economic and technological trends affecting the healthcare industry.

“Today’s developments in the field of genetics, information technologies, and nanotechnology are driving a more individualised approach to healthcare”, says Sumit Sharma, Senior Vice President of Frost & Sullivan’s European Healthcare Practice. “Concepts such as ‘the average patient’ are now viewed as outdated. And standards within modern medical systems are measured by different parameters, including patient access to the best-available treatments and to non-institutionalised care; compliance with treatments; and, even – patient choice”.

The Frost & Sullivan Think Tank aims at understanding the key Megatrends affecting the Healthcare sector, introducing the market from the CEO’s 360 Degree Perspective as well as facilitating unique insights and visions for the participating organisations.

According to David Mason, Programme Director of Frost & Sullivan’s GIL University initiating the Think Tank, participants “will learn how the various healthcare markets will be impacted by ‘convergence’ and how organisations are already reacting to these trends.” The one-day workshop incorporates highly interactive sessions and group discussions to create unique outputs and ensure a wide range of perspectives.

At the end of the day, participants will take home a ‘Convergence Toolkit’ and the opportunity to engage further in an ongoing exchange with other industry members. “Each Think Tank is part of a programme where participants can stay involved and continue to access updated information and share ideas through the Frost & Sullivan Convergence Community”, concludes Mr. Mason.

Frost & Sullivan